These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 31985305

  • 1. Plecanatide for the treatment of constipation-predominant irritable bowel syndrome.
    Miner PB.
    Expert Rev Gastroenterol Hepatol; 2020 Feb; 14(2):71-84. PubMed ID: 31985305
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of plecanatide in treating constipation predominant irritable bowel syndrome.
    Miner PB.
    Expert Opin Pharmacother; 2018 Feb; 19(2):177-183. PubMed ID: 29376436
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Current and emerging treatments for irritable bowel syndrome with constipation and chronic idiopathic constipation: focus on prosecretory agents.
    Thomas RH, Luthin DR.
    Pharmacotherapy; 2015 Jun; 35(6):613-30. PubMed ID: 26016701
    [Abstract] [Full Text] [Related]

  • 6. Plecanatide for the treatment of chronic idiopathic constipation in adult patients.
    Bassotti G, Usai Satta P, Bellini M.
    Expert Rev Clin Pharmacol; 2019 Nov; 12(11):1019-1026. PubMed ID: 31575291
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Plecanatide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: Post hoc analyses of placebo-controlled trials in adults with severe constipation.
    Cash BD, Sharma A, Walker A, Laitman AP, Chang L.
    Neurogastroenterol Motil; 2023 Sep; 35(9):e14632. PubMed ID: 37332239
    [Abstract] [Full Text] [Related]

  • 9. Plecanatide: First Global Approval.
    Al-Salama ZT, Syed YY.
    Drugs; 2017 Apr; 77(5):593-598. PubMed ID: 28255961
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of Plecanatide for the Treatment of Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation in Patients 65 Years or Older.
    Menees SB, Franklin H, Chey WD.
    Clin Ther; 2020 Jul; 42(7):1406-1414.e4. PubMed ID: 32660770
    [Abstract] [Full Text] [Related]

  • 11. The use of novel promotility and prosecretory agents for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation.
    Gale JD.
    Adv Ther; 2009 May; 26(5):519-30. PubMed ID: 19444393
    [Abstract] [Full Text] [Related]

  • 12. New pharmacological treatment options for chronic constipation.
    Corsetti M, Tack J.
    Expert Opin Pharmacother; 2014 May; 15(7):927-41. PubMed ID: 24661106
    [Abstract] [Full Text] [Related]

  • 13. Blunted Evoked Prouroguanylin Endocrine Secretion in Chronic Constipation.
    Waldman SA, Tenenbaum R, Foehl HC, Winkle P, Griffin P.
    Clin Transl Gastroenterol; 2019 Jul; 10(7):e00016. PubMed ID: 31318728
    [Abstract] [Full Text] [Related]

  • 14. New pharmacological treatment options for irritable bowel syndrome with constipation.
    Nusrat S, Miner PB.
    Expert Opin Emerg Drugs; 2015 Jul; 20(4):625-36. PubMed ID: 26548544
    [Abstract] [Full Text] [Related]

  • 15. Benefit-Risk Assessment of Plecanatide in the Treatment of Chronic Idiopathic Constipation.
    Miner PB.
    Drug Saf; 2019 May; 42(5):603-615. PubMed ID: 30649746
    [Abstract] [Full Text] [Related]

  • 16. Linaclotide: a novel compound for the treatment of irritable bowel syndrome with constipation.
    Rothstein RD, Friedenberg FK.
    Expert Opin Pharmacother; 2013 Oct; 14(15):2125-32. PubMed ID: 24007408
    [Abstract] [Full Text] [Related]

  • 17. Focus on Pharmacotherapy for Irritable Bowel Syndrome with Constipation.
    Liu JJ, Brenner DM.
    Gastroenterol Clin North Am; 2021 Sep; 50(3):639-653. PubMed ID: 34304792
    [Abstract] [Full Text] [Related]

  • 18. Oral treatment with plecanatide or dolcanatide attenuates visceral hypersensitivity via activation of guanylate cyclase-C in rat models.
    Boulete IM, Thadi A, Beaufrand C, Patwa V, Joshi A, Foss JA, Eddy EP, Eutamene H, Palejwala VA, Theodorou V, Shailubhai K.
    World J Gastroenterol; 2018 May 07; 24(17):1888-1900. PubMed ID: 29740204
    [Abstract] [Full Text] [Related]

  • 19. Recent advances in the pharmacological management of constipation predominant irritable bowel syndrome.
    Niewinna K, Zielińska A, Fichna J.
    Expert Opin Pharmacother; 2020 Jan 07; 21(1):73-84. PubMed ID: 31724881
    [Abstract] [Full Text] [Related]

  • 20. Plecanatide Improves Abdominal Bloating and Bowel Symptoms of Irritable Bowel Syndrome with Constipation.
    Brenner DM, Sharma A, Rao SSC, Laitman AP, Heimanson Z, Allen C, Sayuk GS.
    Dig Dis Sci; 2024 May 07; 69(5):1731-1738. PubMed ID: 38594429
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.